Last reviewed · How we verify
Influence of the Proton Pump Inhibitor Omeprazole on the Anti-Platelet of P2Y12 Antagonists in Subjects With Coronary and Peripheral Artery Disease
To determine if prasugrel is superior to clopidogrel in providing adequate antiplatelet effect in a high risk population that requires concomitant use of a Proton Pump Inhibitor (PPI).
Details
| Lead sponsor | University of Oklahoma |
|---|---|
| Status | COMPLETED |
| Enrolment | 30 |
| Start date | 2010-01 |
| Completion | 2011-06 |
Conditions
- Coronary Artery Disease
- Peripheral Artery Disease
Countries
United States